Literature DB >> 32905494

Novel genetic variants of SYK and ITGA1 related lymphangiogenesis signaling pathway predict non-small cell lung cancer survival.

Lihua Liu1,2,3, Hongliang Liu2,3, Sheng Luo4, Edward F Patz2,5, Carolyn Glass2,6, Li Su7, Lijuan Lin7, David C Christiani7,8, Qingyi Wei2,3,9.   

Abstract

Although lymphangiogenesis is a vital step in lung cancer metastasis, the association between lymphangiogenesis and non-small cell lung cancer (NSCLC) survival remains unclear. Since single-nucleotide polymorphisms (SNPs) have been reported to predict NSCLC survival, we investigated associations between SNPs in lymphangiogenesis-related pathway genes and NSCLC survival in a discovery genotyping dataset of 1,185 patients from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and validated the findings in another genotyping dataset of 984 patients from the Harvard Lung Cancer Susceptibility Study. We evaluated associations between 34,509 genetic variants (3252 genotyped and 31,257 imputed) in 247 genes involved in lymphangiogenesis-related pathway and NSCLC survival. After validation, we finally identified two independent SNPs (SYK rs11787670 A>G and ITGA1 rs67715745 T>C) to be significantly associated with NSCLC overall survival (OS), with adjusted hazards ratios of 0.77 and 0.83 (95% confidence interval =0.66-0.90, P=7.20×10-4) and 0.84 (95% confidence interval =0.75-0.92, P=3.50×10-4), respectively. Moreover, an increasing number of combined protective alleles of these two SNPs was significantly associated with an improved NSCLC OS and disease-specific survival (DSS) in the PLCO dataset (P trend=0.011 and 0.006, respectively). Furthermore, the addition of these protective alleles to the prediction model for the 5-year survival increased the time-dependent area under the curve both from 87% to 87.67% for OS (P=0.029) and from 88.54% to 89.06% for DSS (P=0.022). Subsequent expression quantitative trait loci (eQTL) functional analysis revealed that the rs11787670 G allele was significantly associated with an elevated SYK mRNA expression in normal tissues. Additional analyses suggested a suppressor role for both SYK and ITGA1 in NSCLC survival. Collectively, these findings indicated that SYK rs11787670 A>G and ITGA1 rs67715745 T>C may be independent prognostic factors for NSCLC survival once further validated. AJCR
Copyright © 2020.

Entities:  

Keywords:  Non-small cell lung cancer; lymphangiogenesis; single-nucleotide polymorphism; survival

Year:  2020        PMID: 32905494      PMCID: PMC7471352     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  43 in total

1.  GenABEL: an R library for genome-wide association analysis.

Authors:  Yurii S Aulchenko; Stephan Ripke; Aaron Isaacs; Cornelia M van Duijn
Journal:  Bioinformatics       Date:  2007-03-23       Impact factor: 6.937

2.  Rare TP53 genetic variant associated with glioma risk and outcome.

Authors:  Kathleen M Egan; L Burton Nabors; Jeffrey J Olson; Alvaro N Monteiro; James E Browning; Melissa H Madden; Reid C Thompson
Journal:  J Med Genet       Date:  2012-06-15       Impact factor: 6.318

3.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

Review 4.  Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?

Authors:  Bartomeu Massuti; Jose Miguel Sanchez; Florentino Hernando-Trancho; Niki Karachaliou; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2013-06

5.  Involvement of syk and VEGF-C in invasion of lung adenocarcinoma A549 cells.

Authors:  Qifeng Sun; Chuanliang Peng; Bo Cong; Yingtao Hao; Jiazhong Guo; Yunpeng Zhao; Xiaogang Zhao
Journal:  J Cancer Res Ther       Date:  2016 Apr-Jun       Impact factor: 1.805

6.  Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.

Authors:  Marialena Trivella; Francesco Pezzella; Ugo Pastorino; Adrian L Harris; Douglas G Altman
Journal:  Lancet Oncol       Date:  2007-06       Impact factor: 41.316

Review 7.  GWAS in cancer: progress and challenges.

Authors:  Baiqiang Liang; Hongrong Ding; Lianfang Huang; Haiqing Luo; Xiao Zhu
Journal:  Mol Genet Genomics       Date:  2020-02-11       Impact factor: 3.291

8.  Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans.

Authors: 
Journal:  Science       Date:  2015-05-07       Impact factor: 47.728

Review 9.  Role of lymphangiogenesis in lung cancer.

Authors:  Bozena Weryńska; Piotr Dziegiel; Renata Jankowska
Journal:  Folia Histochem Cytobiol       Date:  2009-01       Impact factor: 1.698

10.  Transcriptome and genome sequencing uncovers functional variation in humans.

Authors:  Tuuli Lappalainen; Michael Sammeth; Marc R Friedländer; Peter A C 't Hoen; Jean Monlong; Manuel A Rivas; Mar Gonzàlez-Porta; Natalja Kurbatova; Thasso Griebel; Pedro G Ferreira; Matthias Barann; Thomas Wieland; Liliana Greger; Maarten van Iterson; Jonas Almlöf; Paolo Ribeca; Irina Pulyakhina; Daniela Esser; Thomas Giger; Andrew Tikhonov; Marc Sultan; Gabrielle Bertier; Daniel G MacArthur; Monkol Lek; Esther Lizano; Henk P J Buermans; Ismael Padioleau; Thomas Schwarzmayr; Olof Karlberg; Halit Ongen; Helena Kilpinen; Sergi Beltran; Marta Gut; Katja Kahlem; Vyacheslav Amstislavskiy; Oliver Stegle; Matti Pirinen; Stephen B Montgomery; Peter Donnelly; Mark I McCarthy; Paul Flicek; Tim M Strom; Hans Lehrach; Stefan Schreiber; Ralf Sudbrak; Angel Carracedo; Stylianos E Antonarakis; Robert Häsler; Ann-Christine Syvänen; Gert-Jan van Ommen; Alvis Brazma; Thomas Meitinger; Philip Rosenstiel; Roderic Guigó; Ivo G Gut; Xavier Estivill; Emmanouil T Dermitzakis
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  1 in total

1.  ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing.

Authors:  Zhaojie Qin; Kai Luo; Wenyu Feng; Xinli Zhan; Yun Liu; Shijie Liao; Juliang He; Mingwei He; Tianyu Xie; Xiaohong Jiang; Boxiang Li; Huijiang Liu; Qian Huang; Haijun Tang
Journal:  Int J Gen Med       Date:  2022-02-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.